If a severely obese patient (BMI 35 to 39.9) with one or more health conditions, or a morbidly obese patient (BMI 40 or greater), has not reached 10% TBWL in six months, they should be referred for bariatric surgery
doi: 10.1001/jama.2019.22360 57 JankovicJTanEK
Explore the case study and see how polymer science is shaping the future of drug development: USP Case Study Lupron Depot #USP #PolymerScience #DrugDevelopment #PharmaceuticalInnovation #LupronDepot #PLGA #Biopharma #QualityStandards #RegulatoryCompliance #LongActingInjectables To view or add a comment, sign in Poly(N-isopropylacrylamide) (PNIPAM) Consider how PNIPAM transforms a raw active ingredient into a stable, injectable formulation that releases drug precisely when needed
Thats well above what Rybelsus delivers
The search for compounds that can enhance memory, learning, and brain repair has led researchers into the world of neuropeptides
Steroids and L-lysine aescinatefor acute radiculopathy due to a herniated lumbar disk